자료유형 | 학위논문 |
---|---|
서명/저자사항 | Targeting CD133 in Androgen Receptor Indifferent, Neuroendocrine Differentiated Aggressive Variant Prostate Cancer. |
개인저자 | Glumac, Paige M. |
단체저자명 | University of Minnesota. Pharmacology. |
발행사항 | [S.l.]: University of Minnesota., 2019. |
발행사항 | Ann Arbor: ProQuest Dissertations & Theses, 2019. |
형태사항 | 137 p. |
기본자료 저록 | Dissertations Abstracts International 81-03B. Dissertation Abstract International |
ISBN | 9781085733519 |
학위논문주기 | Thesis (Ph.D.)--University of Minnesota, 2019. |
일반주기 |
Source: Dissertations Abstracts International, Volume: 81-03, Section: B.
Advisor: LeBeau, Aaron. |
이용제한사항 | This item must not be sold to any third party vendors. |
요약 | An increasing number of men are developing a lethal, non-androgen receptor (AR) driven form of prostate cancer (PCa) known as aggressive variant prostate cancer (AVPC). Therapeutic options for AVPC are limited, and the development of novel therapeutics is significantly hindered by the inability to accurately monitor the disease through imaging. This underscores the critical need to develop improved imaging agents for AVPC. Targeted imaging agents, such as those developed for prostate-specific membrane antigen (PSMA) have made significant progress in imaging metastatic prostate adenocarcinoma |
일반주제명 | Pharmacology. Medicine. |
언어 | 영어 |
바로가기 |
: 이 자료의 원문은 한국교육학술정보원에서 제공합니다. |